New Hope For Esophageal Cancer Patients — Immunotherapy Opdivo Approved For Treatment Of Advanced Esophageal Cancer

Checkpoint inhibitor OPDIVO has shown tremendous promise for patients battling advanced esophageal cancer.

Leave a comment



Leave a Reply

Your email address will not be published. Required fields are marked *